BNTX US09075V1026

Report

Delayed Nasdaq - 10/22 04:00:00 pm
278.34	USD		-2.80%

10/22	Health Care Up On Defensive Bias -- Health Care Roundup	DJ
10/22	MODERNA : COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines may confer greater protection	RE
10/22	Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots	RE

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

10/18/2021	10/19/2021	10/20/2021	10/21/2021	10/22/2021	Date
261.09(c)	262.85(c)	269.42(c)	286.36(c)	278.34(c)	Last
2 011 888	3 854 495	2 029 221	2 558 793	3 542 012	Volume
+5.41%	+0.67%	+2.50%	+6.29%	-2.80%	Change

More quotes

Estimated financial data (e)

Sales 2021	16 703 M 19 447 M 19 447 M
Net income 2021	8 797 M 10 242 M 10 242 M
Net cash position 2021	8 661 M 10 084 M 10 084 M
P/E ratio 2021	6,80x
Yield 2021	-

Sales 2022	16 697 M 19 441 M 19 441 M
Net income 2022	9 328 M 10 861 M 10 861 M
Net cash position 2022	18 931 M 22 041 M 22 041 M
P/E ratio 2022	6,61x
Yield 2022	-

Capitalization	57 719 M 67 225 M 67 202 M
EV / Sales 2021	2,94x
EV / Sales 2022	2,32x
Nbr of Employees	2 500
Free-Float	87,3%

More Financials

Company

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer...

Sector

Biotechnology & Medical Research

Calendar

11/01

Presentation

More about the company

Ratings of BioNTech SE

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

All news about BIONTECH SE

10/22	Health Care Up On Defensive Bias -- Health Care Roundup	DJ
10/22	MODERNA : COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines ma..	RE
10/22	Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots	RE
10/22	PFIZER : FDA Panel to Vote on Pfizer COVID-19 Shots for Kids; Data Shows Vaccine 90.7% Eff..	MT
10/22	European ADRs Move Higher in Friday Trading	MT
10/22	PFIZER : Norway Stops Second Dose COVID-19 Vaccine Inoculations For Minors	MT
10/22	PFIZER : BioNTech COVID-19 Vaccine Shows Nearly 91% Efficacy in Kids	MT
10/22	BIONTECH : Deutsche Bank Starts BioNTech at Hold with $250 Price Target	MT
10/22	PFIZER : BioNTech COVID Vaccine Reportedly Shows Nearly 91% Efficacy in Kids	MT
10/21	Health Care Up As BioNTech Rallies -- Health Care Roundup	DJ
10/21	PFIZER WILL SHIP MILLIONS OF VACCINE : Trudeau	AQ
10/21	BIONTECH : Shares Rise After Data Shows Efficacy of COVID-19 Vaccine's Booster Dose	MT
10/21	GLOBAL MARKETS LIVE : Tesla, Unilever, Paypal, Elliott, Novartis...
10/21	Canada, Pfizer Strike Deal on Pediatric Vaccine Doses	DJ
10/21	European ADRs Move Lower in Thursday Trading	MT

More news

News in other languages on BIONTECH SE

10/23	Vaccin Pfizer voldoet aan criteria FDA voor immuunrespons jonge kinderen
10/22	Le comité de la FDA votera sur les vaccins COVID-19 de Pfizer destinés aux enfants ; le..
10/22	CORONA-BLOG/Biontech-Impfstoff bei Kindern zu knapp 91% wirksam
10/22	Les ADR européens sont en hausse vendredi
10/22	COVID : Pfizer revendique une efficacité de 90% pour le vaccin chez les 5-11 ans

More news

Analyst Recommendations on BIONTECH SE

10/22	BIONTECH : Deutsche Bank Starts BioNTech at Hold with $250 Price Target	MT
10/07	BIONTECH : Jefferies Starts BioNTech at Hold With $230 Price Target	MT
10/07	BIONTECH : Jefferies reaffirms its Neutral rating	MD

More recommendations

Provided by Scoopnest.com

Analysis

Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots